Open AccessLevofloxacin versus ceftriaxone and azithromycin for treating community-acquired pneumonia: a randomized clinical trial study
Author(s) -
Davood Yadegarynia,
Shabnam Tehrani,
Fatemeh Maghsoudi Nejad,
Fatemeh Shojaeian,
Amirreza Keyvanfar
Publication year - 2022
Publication title -
iranian journal of microbiology.
Language(s) - English
Resource type - Journals
eISSN - 2008-4447
pISSN - 2008-3289
DOI - 10.18502/ijm.v14i4.10231
Subject(s) - levofloxacin , medicine , ceftriaxone , azithromycin , community acquired pneumonia , randomized controlled trial , pneumonia , antibiotics , cephalosporin , microbiology and biotechnology , biology
We compared two common antibiotic regimens for the treatment of mild to moderate CAP: levofloxacin versus β-lactam and macrolide combination; in terms of their efficacy and side effects.